[Processes of absorption and utilization of glucose in newborn infants with intrauterine hypotrophy]

Pediatriia
|January 1, 1992
PubMed

Insights

Neonates with intrauterine hypotrophy show increased glucose absorption and delayed utilization. This suggests pancreatic insufficiency in affected infants, impacting glucose metabolism.

Area of Science:

  • Neonatology
  • Endocrinology
  • Metabolic Disorders

Background:

  • Intrauterine hypotrophy (IH) poses significant health risks to neonates.
  • Understanding glucose metabolism is crucial for assessing neonatal health.
  • Glucose tolerance testing is a standard diagnostic tool.

Purpose of the Study:

  • To investigate glucose absorption and utilization in neonates with intrauterine hypotrophy.
  • To evaluate pancreatic function in IH neonates using glucose tolerance test data.

Main Methods:

  • Glucose tolerance tests were performed on 75 neonates with IH and 19 healthy controls.
  • Analysis focused on glucose absorption rates and utilization patterns.

Main Results:

  • IH neonates exhibited significantly increased glucose absorption.
  • A notable retardation in glucose utilization was observed in IH neonates.
  • Elevated blood glucose levels at 2 hours post-test indicated impaired glucose handling.

Conclusions:

  • Intrauterine hypotrophy is associated with altered glucose absorption and utilization.
  • Findings suggest functional insufficiency of the pancreas in neonates with IH.
  • These metabolic disturbances highlight the need for closer monitoring of IH neonates.

Related Concept Videos

Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Glucose Absorption Into the Small Intestine01:26

Glucose Absorption Into the Small Intestine

Complex carbohydrates consumed cannot be absorbed into the small intestine in their original form. First, they must be hydrolyzed to a monosaccharide form such as glucose or galactose. These monosaccharides are then transported across the intestinal membrane and into the blood via transcellular transport. The intestinal epithelial cells allow the movement of these monosaccharides with a defined 'entry' through membrane transporter proteins present on their apical membrane and 'exit' via the...
Carbohydrate Absorption01:25

Carbohydrate Absorption

Carbohydrates are essential macronutrients that serve as the body's primary energy source. Their digestion begins in the mouth, where salivary amylase partially breaks down complex carbohydrates such as starch into smaller oligosaccharides. This mechanical and enzymatic activity prepares carbohydrates for further processing in the gastrointestinal tract.
After being swallowed, the partially digested carbohydrates mix with gastric secretions in the stomach. However, the acidic environment...
Metabolic States of the Body: The Absorptive State01:25

Metabolic States of the Body: The Absorptive State

During the absorptive state, which lasts approximately four hours after a meal, the body absorbs nutrients from the gastrointestinal tract. The carbohydrates, proteins, and lipids we consume are broken down into monosaccharides, amino acids, and free fatty acids for absorption. While carbohydrates and proteins are absorbed as-is, lipids are absorbed in their broken-down forms and then re-esterified into triglycerides within enterocytes before being packaged into chylomicrons. These absorbed...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...